Skip to content

Screening of serum biomarkers for rheumatoid arthritis combined with pulmonary interstitial lesions

Screening of serum biomarkers for rheumatoid arthritis combined with pulmonary interstitial lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086413
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

RA-ILD Group:Natural queue,Take the blood samples
RA non-ILD Group:Natural queue,Take the blood samples

Sponsors

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 and above; (2) Complies with the 2010 American College of Rheumatology (ACR)/European Union Against Rheumatology (EULAR) classification criteria; Meets ILD diagnostic criteria (3) The patient is informed and agrees to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Patients with end-stage renal disease, grade IV heart failure (NYHA grading), liver failure, sepsis, and malignant tumors; (3) Patients with other rheumatic and immune diseases, such as systemic lupus erythematosus, systemic sclerosis, and mixed Connective tissue disease, etc; (4) Concomitant with other lung diseases, such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary tuberculosis, lung tumors, etc;

Design outcomes

Primary

MeasureTime frame
plasma protein;

Countries

China

Contacts

Public ContactPeng Jiangyun

Yunnan Hospital of Traditional Chinese Medicine

pengjiangyun@126.com+86 130 9996 3399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026